Cargando…

Balancing the Efficacy and Safety of Implementing a Piperacillin/tazobactam (PTZ) Antibiotic Time-out

BACKGROUND: With the rise of antimicrobial resistance, the Centers for Disease Control and Joint Commission have promulgated a national initiative for antimicrobial stewardship programs (ASP). ASP use a multimodal approach such as antibiotic time outs to limit the duration of empiric therapy. Yale N...

Descripción completa

Detalles Bibliográficos
Autores principales: Jammal, Nadya, Mcmanus, Dayna, Tirmizi, Samad, Topal, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630706/
http://dx.doi.org/10.1093/ofid/ofx163.1255
_version_ 1783269273167200256
author Jammal, Nadya
Mcmanus, Dayna
Tirmizi, Samad
Topal, Jeffrey
author_facet Jammal, Nadya
Mcmanus, Dayna
Tirmizi, Samad
Topal, Jeffrey
author_sort Jammal, Nadya
collection PubMed
description BACKGROUND: With the rise of antimicrobial resistance, the Centers for Disease Control and Joint Commission have promulgated a national initiative for antimicrobial stewardship programs (ASP). ASP use a multimodal approach such as antibiotic time outs to limit the duration of empiric therapy. Yale New Haven Hospital implemented the use of a 72-hour stop in the electronic medical system (EMR) for empiric PTZ orders. To mitigate the risk of orders inadvertently falling off, a dynamic scoring system was created in the EMR to alert pharmacists of expiring orders in real time. The primary objective of this study was to evaluate the duration of empiric PTZ prior to and after the implementation of the antibiotic time-out. Secondary outcomes included de-escalation, appropriateness of dosing, and safety. METHODS: A retrospective cohort study using the EMR was conducted. Cases were defined as adult inpatients who had empiric orders for PTZ without positive cultures. The control group consisted of patients from September to October of 2014, prior to the 72-hour stop. The intervention group included patients from September to October of 2016. Due to the nationwide shortage of PTZ in 2015, this year was excluded in addition to patients with culture documented infections, stem cell/solid organ transplants or febrile neutropenia. Data collected included baseline demographics, renal function, PTZ dose, frequency and duration, indication and final antibiotic selection. RESULTS: Of the 537 random patients reviewed, 300 met inclusion criteria; 150 patients in the control group and 150 patients in the intervention group. The average duration of PTZ decreased from 4 days in the control group to 3 days in the intervention group (P = 0.0013). Overall antibiotic use decreased from 6 days in the control group to 5 days in the intervention group (P = <0.0001). There was an increase in the correct dose and frequency from 35% to 60% of orders in the intervention group compared with the control group (P = 0.004). With the aid of the scoring system, there were no orders that fell off inappropriately in the intervention group. CONCLUSION: Following the successful implementation of a 72-hour antibiotic timeout we saw a significant decrease in the duration of empiric use, inappropriate dosing and an increase in the rate of antibiotic de-escalation. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5630706
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56307062017-11-07 Balancing the Efficacy and Safety of Implementing a Piperacillin/tazobactam (PTZ) Antibiotic Time-out Jammal, Nadya Mcmanus, Dayna Tirmizi, Samad Topal, Jeffrey Open Forum Infect Dis Abstracts BACKGROUND: With the rise of antimicrobial resistance, the Centers for Disease Control and Joint Commission have promulgated a national initiative for antimicrobial stewardship programs (ASP). ASP use a multimodal approach such as antibiotic time outs to limit the duration of empiric therapy. Yale New Haven Hospital implemented the use of a 72-hour stop in the electronic medical system (EMR) for empiric PTZ orders. To mitigate the risk of orders inadvertently falling off, a dynamic scoring system was created in the EMR to alert pharmacists of expiring orders in real time. The primary objective of this study was to evaluate the duration of empiric PTZ prior to and after the implementation of the antibiotic time-out. Secondary outcomes included de-escalation, appropriateness of dosing, and safety. METHODS: A retrospective cohort study using the EMR was conducted. Cases were defined as adult inpatients who had empiric orders for PTZ without positive cultures. The control group consisted of patients from September to October of 2014, prior to the 72-hour stop. The intervention group included patients from September to October of 2016. Due to the nationwide shortage of PTZ in 2015, this year was excluded in addition to patients with culture documented infections, stem cell/solid organ transplants or febrile neutropenia. Data collected included baseline demographics, renal function, PTZ dose, frequency and duration, indication and final antibiotic selection. RESULTS: Of the 537 random patients reviewed, 300 met inclusion criteria; 150 patients in the control group and 150 patients in the intervention group. The average duration of PTZ decreased from 4 days in the control group to 3 days in the intervention group (P = 0.0013). Overall antibiotic use decreased from 6 days in the control group to 5 days in the intervention group (P = <0.0001). There was an increase in the correct dose and frequency from 35% to 60% of orders in the intervention group compared with the control group (P = 0.004). With the aid of the scoring system, there were no orders that fell off inappropriately in the intervention group. CONCLUSION: Following the successful implementation of a 72-hour antibiotic timeout we saw a significant decrease in the duration of empiric use, inappropriate dosing and an increase in the rate of antibiotic de-escalation. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5630706/ http://dx.doi.org/10.1093/ofid/ofx163.1255 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Jammal, Nadya
Mcmanus, Dayna
Tirmizi, Samad
Topal, Jeffrey
Balancing the Efficacy and Safety of Implementing a Piperacillin/tazobactam (PTZ) Antibiotic Time-out
title Balancing the Efficacy and Safety of Implementing a Piperacillin/tazobactam (PTZ) Antibiotic Time-out
title_full Balancing the Efficacy and Safety of Implementing a Piperacillin/tazobactam (PTZ) Antibiotic Time-out
title_fullStr Balancing the Efficacy and Safety of Implementing a Piperacillin/tazobactam (PTZ) Antibiotic Time-out
title_full_unstemmed Balancing the Efficacy and Safety of Implementing a Piperacillin/tazobactam (PTZ) Antibiotic Time-out
title_short Balancing the Efficacy and Safety of Implementing a Piperacillin/tazobactam (PTZ) Antibiotic Time-out
title_sort balancing the efficacy and safety of implementing a piperacillin/tazobactam (ptz) antibiotic time-out
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630706/
http://dx.doi.org/10.1093/ofid/ofx163.1255
work_keys_str_mv AT jammalnadya balancingtheefficacyandsafetyofimplementingapiperacillintazobactamptzantibiotictimeout
AT mcmanusdayna balancingtheefficacyandsafetyofimplementingapiperacillintazobactamptzantibiotictimeout
AT tirmizisamad balancingtheefficacyandsafetyofimplementingapiperacillintazobactamptzantibiotictimeout
AT topaljeffrey balancingtheefficacyandsafetyofimplementingapiperacillintazobactamptzantibiotictimeout